Search details
1.
Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV-1 Virus.
Small
; 18(13): e2104763, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35076148
2.
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial.
Mol Ther
; 27(11): 1930-1938, 2019 11 06.
Article
in English
| MEDLINE | ID: mdl-31570234
3.
Retraction for Zachos et al., "Herpes Simplex Virus Type 1 Blocks the Apoptotic Host Cell Defense Mechanisms That Target Bcl-2 and Manipulates Activation of p38 Mitogen-Activated Protein Kinase to Improve Viral Replication".
J Virol
; 96(18): e0104422, 2022 Sep 28.
Article
in English
| MEDLINE | ID: mdl-36040177
4.
HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models.
Viruses
; 15(3)2023 02 22.
Article
in English
| MEDLINE | ID: mdl-36992311
5.
Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability.
Front Mol Biosci
; 9: 889395, 2022.
Article
in English
| MEDLINE | ID: mdl-35782876
6.
Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma.
iScience
; 24(7): 102759, 2021 Jul 23.
Article
in English
| MEDLINE | ID: mdl-34278266
7.
Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors.
Mol Cancer Ther
; 20(3): 589-601, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33298589
8.
Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716.
Lung Cancer
; 150: 145-151, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33160198
9.
Please stand by: how oncolytic viruses impact bystander cells.
Future Virol
; 13(9): 671-680, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-30416535
10.
High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy.
Viruses
; 10(3)2018 03 15.
Article
in English
| MEDLINE | ID: mdl-29543735
11.
TGF-ß Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma.
Mol Ther Oncolytics
; 7: 17-26, 2017 Dec 15.
Article
in English
| MEDLINE | ID: mdl-29034312
12.
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models.
Sci Rep
; 7(1): 2396, 2017 05 24.
Article
in English
| MEDLINE | ID: mdl-28539588
13.
Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion.
Mol Ther Oncolytics
; 5: 75-86, 2017 Jun 16.
Article
in English
| MEDLINE | ID: mdl-28547002
14.
Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation.
Oncotarget
; 8(11): 17412-17427, 2017 Mar 14.
Article
in English
| MEDLINE | ID: mdl-28147331
15.
Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients.
Clin Cancer Res
; 23(14): 3566-3574, 2017 Jul 15.
Article
in English
| MEDLINE | ID: mdl-28495911
16.
Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire.
J Neuroimmunol
; 165(1-2): 92-103, 2005 Aug.
Article
in English
| MEDLINE | ID: mdl-15967512
17.
Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting.
Nat Commun
; 6: 8009, 2015 Aug 18.
Article
in English
| MEDLINE | ID: mdl-26284300
18.
Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes.
J Neuroimmunol
; 152(1-2): 98-111, 2004 Jul.
Article
in English
| MEDLINE | ID: mdl-15223242
19.
Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models.
J Hepatocell Carcinoma
; 1: 149-61, 2014.
Article
in English
| MEDLINE | ID: mdl-27508184
20.
Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs.
Oncolytic Virother
; 2: 57-74, 2013.
Article
in English
| MEDLINE | ID: mdl-27512658